8W0Q | pdb_00008w0q

Pembrolizumab CDR-H3 Loop Mimic

  • Classification: IMMUNE SYSTEM
  • Organism(s): Homo sapiens
  • Mutation(s): No 

  • Deposited: 2024-02-14 Released: 2024-07-03 
  • Deposition Author(s): Feig, M., Roche, S.P.
  • Funding Organization(s): National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)

Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 53799 
  • Conformers Submitted: 20 
  • Selection Criteria: back calculated data agree with experimental NOESY spectrum 

wwPDB Validation 3D Report Full Report

Validation slider image for 8W0Q

This is version 1.2 of the entry. See complete history

Literature

De Novo Synthesis and Structural Elucidation of CDR-H3 Loop Mimics.

Zhao, G.Richaud, A.D.Williamson, R.T.Feig, M.Roche, S.P.

(2024) ACS Chem Biol 19: 1583-1592

  • DOI: https://doi.org/10.1021/acschembio.4c00236
  • Primary Citation Related Structures: 
    8W0Q

  • PubMed Abstract: 

    The binding affinity of antibodies to specific antigens stems from a remarkably broad repertoire of hypervariable loops known as complementarity-determining regions (CDRs). While recognizing the pivotal role of the heavy-chain 3 CDRs (CDR-H3s) in maximizing antibody-antigen affinity and specificity, the key structural determinants responsible for their adaptability to diverse loop sequences, lengths, and noncanonical structures are hitherto unknown. To address this question, we achieved a de novo synthesis of bulged CDR-H3 mimics excised from their full antibody context. CD and NMR data revealed that these stable standalone β-hairpin scaffolds are well-folded and retain many of the native bulge CDR-H3 features in water. In particular, the tryptophan residue, highly conserved across CDR-H3 sequences, was found to extend the kinked base of these β-bulges through a combination of stabilizing intramolecular hydrogen bond and CH/π interaction. The structural ensemble consistent with our NMR observations exposed the dynamic nature of residues at the base of the loop, suggesting that β-bulges act as molecular hinges connecting the rigid stem to the more flexible loops of CDR-H3s. We anticipate that this deeper structural understanding of CDR-H3s will lay the foundation to inform the design of antibody drugs broadly and engineer novel CDR-H3 peptide scaffolds as therapeutics.


  • Organizational Affiliation
    • Department of Chemistry and Biochemistry, Florida Atlantic University, Boca Raton, Florida 33431, United States.

Macromolecule Content 

  • Total Structure Weight: 2.67 kDa 
  • Atom Count: 190 
  • Modeled Residue Count: 20 
  • Deposited Residue Count: 20 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:  Sequence   |   3D Structure  
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Pembrolizumab CDR-H3 Loop Mimic20Homo sapiensMutation(s): 0 

Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 53799 
  • Conformers Submitted: 20 
  • Selection Criteria: back calculated data agree with experimental NOESY spectrum 

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesR21 GM132754
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesR35 GM126948

Revision History  (Full details and data files)

  • Version 1.0: 2024-07-03
    Type: Initial release
  • Version 1.1: 2024-07-10
    Changes: Database references
  • Version 1.2: 2024-07-31
    Changes: Database references